Literature DB >> 3492908

QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole.

J A Lopez, J G Harold, M C Rosenthal, D S Oseran, J N Schapira, T Peter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3492908     DOI： 10.1016/0002-9149(87)90824-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  13 in total

Review 1.  Cardiovascular manifestations of HIV infection.

Authors:  G Barbaro
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

Review 2.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

3.  QTc interval prolongation in patients with HIV and AIDS.

Authors:  Mahmoud U Sani; Basil N Okeahialam
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

Review 4.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 5.  Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.

Authors:  Fabrizio De Ponti; Elisabetta Poluzzi; Andrea Cavalli; Maurizio Recanatini; Nicola Montanaro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  A common polymorphism associated with antibiotic-induced cardiac arrhythmia.

Authors:  F Sesti; G W Abbott; J Wei; K T Murray; S Saksena; P J Schwartz; S G Priori; D M Roden; A L George; S A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 7.  Drug interactions with cisapride: clinical implications.

Authors:  E L Michalets; C R Williams
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

Review 8.  QT prolongation with antimicrobial agents: understanding the significance.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans.

Authors:  Jessie Torgersen; Scarlett L Bellamy; Bakgaki Ratshaa; Xiaoyan Han; Mosepele Mosepele; Athena F Zuppa; Marijana Vujkovic; Andrew P Steenhoff; Gregory P Bisson; Robert Gross
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-04       Impact factor: 2.441

10.  QTc interval prolongation in HIV-infected patients: a case-control study by 24-hour Holter ECG recording.

Authors:  Alessandra Fiorentini; Nicola Petrosillo; Angelo Di Stefano; Stefania Cicalini; Laura Borgognoni; Evangelo Boumis; Luigi Tubani; Pierangelo Chinello
Journal:  BMC Cardiovasc Disord       Date:  2012-12-23       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.